Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  35 results for ""Neovascularization, Physiologic drug effects""

Your Filters

Publisher : elsevier science ireland Filter by : Subject Phrase
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Acetyl-l-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways.

  • Authors : Baci D; Laboratory of Vascular Biology and Angiogenesis, IRCCS MultiMedica, Milan, Italy.; Bruno A

Subjects: Acetylcarnitine/Acetylcarnitine/Acetylcarnitine/*pharmacology ; Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*pharmacology ; Receptors, CXCR4/Receptors, CXCR4/Receptors, CXCR4/*metabolism

  • Source: Cancer letters [Cancer Lett] 2018 Aug 10; Vol. 429, pp. 100-116. Date of Electronic Publication: 2018 Apr 18.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.

  • Authors : Sui H; Department of Medical Oncology & Cancer Institute of Integrative Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.; Zhao J

Subjects: Neovascularization, Pathologic* ; Tumor Hypoxia* ; Tumor Microenvironment*

  • Source: Cancer letters [Cancer Lett] 2017 Sep 10; Vol. 403, pp. 86-97. Date of Electronic Publication: 2017 Jun 07.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.

  • Authors : Liang S; Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.; Chen Z

Subjects: Neovascularization, Pathologic*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Cell Movement/Cell Movement/Cell Movement/*drug effects

  • Source: Cancer letters [Cancer Lett] 2017 Feb 01; Vol. 386, pp. 12-23. Date of Electronic Publication: 2016 Nov 09.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

The noni anthraquinone damnacanthal is a multi-kinase inhibitor with potent anti-angiogenic effects.

  • Authors : García-Vilas JA; Universidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, E-29071 Málaga, Spain; IBIMA (Biomedical Research Institute of Málaga), E-29071 Málaga, Spain.

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*pharmacology ; Anthraquinones/Anthraquinones/Anthraquinones/*pharmacology ; Chorioallantoic Membrane/Chorioallantoic Membrane/Chorioallantoic Membrane/*blood supply

  • Source: Cancer letters [Cancer Lett] 2017 Jan 28; Vol. 385, pp. 1-11. Date of Electronic Publication: 2016 Nov 02.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.

  • Authors : Chen H; Glycochemistry and Glycobiology Lab, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China; Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China

Subjects: Neovascularization, Pathologic*; Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*pharmacology ; Cell Proliferation/Cell Proliferation/Cell Proliferation/*drug effects

  • Source: Cancer letters [Cancer Lett] 2016 Nov 01; Vol. 382 (1), pp. 44-52. Date of Electronic Publication: 2016 Aug 26.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells.

  • Authors : Lin R; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Otorhinolaryngology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*pharmacology ; Apoptosis/Apoptosis/Apoptosis/*drug effects ; Artemisinins/Artemisinins/Artemisinins/*pharmacology

  • Source: Cancer letters [Cancer Lett] 2016 Oct 10; Vol. 381 (1), pp. 165-75. Date of Electronic Publication: 2016 Jul 28.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Acute myeloid leukemia in the vascular niche.

  • Authors : Cogle CR; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: .; Bosse RC

Subjects: Tumor Microenvironment*; Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*therapeutic use ; Bone Marrow/Bone Marrow/Bone Marrow/*blood supply

  • Source: Cancer letters [Cancer Lett] 2016 Oct 01; Vol. 380 (2), pp. 552-560. Date of Electronic Publication: 2015 May 08.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.

  • Authors : Li D; School of Life Sciences and Technology, Tongji University, Shanghai, China.; Xie K

Subjects: Neovascularization, Pathologic*; Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*pharmacology ; Fibroblast Growth Factor 2/Fibroblast Growth Factor 2/Fibroblast Growth Factor 2/*antagonists & inhibitors

  • Source: Cancer letters [Cancer Lett] 2016 Jul 28; Vol. 377 (2), pp. 164-73. Date of Electronic Publication: 2016 Apr 26.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

MMGZ01, an anti-DLL4 monoclonal antibody, promotes nonfunctional vessels and inhibits breast tumor growth.

  • Authors : Xu Z; State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.; Wang Z

Subjects: Neovascularization, Pathologic*; Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*pharmacology ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*pharmacology

  • Source: Cancer letters [Cancer Lett] 2016 Mar 01; Vol. 372 (1), pp. 118-27. Date of Electronic Publication: 2015 Dec 29.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings.

  • Authors : de Aguiar RB; Departamento de Radiologia e Oncologia, Faculdade de Medicina, Universidade de São Paulo, Avenida Dr Arnaldo 251, 01246-000 São Paulo, SP, Brazil; Departamento de Biofísica, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Botucatu 862, 04023-062 São Paulo, SP, Brazil.

Subjects: Neovascularization, Pathologic*; Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*pharmacology ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*pharmacology

  • Source: Cancer letters [Cancer Lett] 2016 Feb 28; Vol. 371 (2), pp. 151-60. Date of Electronic Publication: 2015 Dec 03.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  35 results for ""Neovascularization, Physiologic drug effects""